Kobe Yuen
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Prostate Cancer Treatment and Research 12
- Ferroptosis and cancer prognosis 2
- Oncology 12
- Cancer Immunotherapy and Biomarkers 12
- Co-authors
- Jennifer L. Gerton (4 shared papers)Sanjeev Mariathasan (17 shared papers)Edward E. Kadel (12 shared papers)Brian D. Slaughter (1 shared paper)Thomas Powles (4 shared papers)Christopher J. Sweeney (3 shared papers)Patrick Williams (3 shared papers)Jennifer Doss (2 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer Research (5 papers)Clinical Cancer Research (3 papers)Journal for ImmunoTherapy of Cancer (2 papers)The Prostate (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Kobe Yuen
26 papers receiving 650 citations
Kobe Yuen's Hit Papers
Peers
Comparison fields: 5 of 58
- Oncology 244
- Immunology 168
- Pulmonary and Respiratory Medicine 226
- Cancer Research 68
- Molecular Biology 233
Countries citing papers authored by Kobe Yuen
This map shows the geographic impact of Kobe Yuen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kobe Yuen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kobe Yuen more than expected).
Fields of papers citing papers by Kobe Yuen
This network shows the impact of papers produced by Kobe Yuen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kobe Yuen. The network helps show where Kobe Yuen may publish in the future.
Co-authors
The 25 scholars most cited alongside Kobe Yuen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial Hit paper breakdown → | 2022 | 170 |
| 2 | 2020 | 67 | |
| 3 | 2021 | 55 | |
| 4 | 2017 | 55 | |
| 5 | 2020 | 47 | |
| 6 | 2021 | 36 | |
| 7 | 2018 | 32 | |
| 8 | 2015 | 31 | |
| 9 | 2022 | 29 | |
| 10 | 2015 | 29 | |
| 11 | 2015 | 24 | |
| 12 | 2020 | 20 | |
| 13 | 2024 | 15 | |
| 14 | 2020 | 12 | |
| 15 | 2017 | 8 | |
| 16 | 2020 | 7 | |
| 17 | 2025 | 6 | |
| 18 | 2019 | 4 | |
| 19 | 2022 | 3 | |
| 20 | 2023 | 2 |
About Kobe Yuen
Kobe Yuen is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 27 papers that have together received 659 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Prostate Cancer Treatment and Research (12 papers), Bladder and Urothelial Cancer Treatments (5 papers), RNA Research and Splicing (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Cancer Genomics and Diagnostics (3 papers), Genomics and Chromatin Dynamics (3 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Oncology (244 citations), Immunology (168 citations), Pulmonary and Respiratory Medicine (226 citations), Cancer Research (68 citations) and Molecular Biology (233 citations). Kobe Yuen has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Jennifer L. Gerton, Sanjeev Mariathasan, Edward E. Kadel, Brian D. Slaughter, Thomas Powles, Christopher J. Sweeney, Patrick Williams, Jennifer Doss, Gary L. Buchschacher and Nobuaki Matsubara. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Journal for ImmunoTherapy of Cancer and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.